2022 Speakers

Take a sneak peek at a few of the speakers we have confirmed for the January 2022 show!

Speakers

Aaron Solis

Director, Business Development • AGC Biologics
Speakers

Abdulkader Rahmo

Chief Scientific Officer • SMSbiotech
Speakers

Aditi Singh

Global Senior Marketing Manager • Sony Biotechnology Inc
Speakers

Alan P Kypson

Cardiac Sugeon • REX Hospital
Speakers

Alex Klarer

Director of Cell Therapy  • BioCentriq
Speakers

Allen Fang

Co-Founder and Chief Scientific Officer • HebeCell Corp
Speakers

Amritha Jaishankar

Executive Director • Maryland Stem Cell Research Fund
Speakers

Andrea Zobel

Senior Director, Personalized Supply Chain • AmerisourceBergen
Speakers

Angela Justice

Chief People Officer • TCR2 Therapeutics
Speakers

Anirban Ghosh

Director, Supply Chain Business Systems Architect • Genentech
Speakers

Anthony Oliva

Senior Scientist • Longeveron
Speakers

Anthony Oliva

Senior Scientist • Longeveron
Speakers

Anthony Renodon

Business Development Officer • TreeFrog Therapeutics
Speakers

Anthony Ting

Chief Scientific Officer • Bone Therapeutics
Speakers

Anthony Ting

Chief Scientific Officer • Bone Therapeutics
Speakers

Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics
Speakers

Barbara A. Binzak Blumenfeld

Shareholder, FDA & Biotechnology • Buchanan Ingersoll Rooney
Speakers

Becky Cap

Chief Operating Officer, GenCure, Senior Vice President • BioBridge Global
Speakers

Blair Clark-Schoeb

Senior Vice President, Communications • Aruvant
Speakers

Boro Dropulic

Executive Director • Caring Cross
Speakers

Breanna Borys

Bioprocess Scientist • PBS Biotech
Speakers

Brian Feth

Co-Founder and Chief Executive Officer • Xcellbio
Speakers

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania
Speakers

Bruce Thompson

Technical Head of Cell Therapy • Resilience
Speakers

Bryan Poltilove

Operational Partner • Broadoak Capital Partners
Speakers

Carmen Brenner

Director, Manufacturing Sciences and Technologies (MSaT) • Novadip
Speakers

Carol Houts

Vice President, Quality and Business Strategy • Germfree
Speakers

Cate Dyer

Chief Executive Officer & Founder • StemExpress, LLC
Speakers

Cedric Ait Mansour

Global Senior Manager Market Development – New Products • Sony Biotechnology Inc
Speakers

Cenk Sumen

Chief Technology Officer • Stemson Therapeutics
Speakers

Chris Reardon

Associate Scientist • Dyno Therapeutics
Speakers

Chris Wegener

Director, Cell Therapy R&D • Fresenius Kabi
Speakers

Christa Feasley

 • Cytovance Biologics
Speakers

Christopher Ballas

Senior Vice President, Manufacturing • Innovative Cellular Therapeutics
Speakers

Clark Paramore

Head of Value Demonstration, Vice President of HEOR • bluebird bio
Speakers

Craig Shepherd

Senior Managing Director • Blackstone Life Sciences
Speakers

Craig Shepherd

Senior Managing Director • Blackstone Life Sciences
Speakers

Dale Hanna

Director of Product • AmerisourceBergen
Speakers

Dan Gincel

Senior Vice President • Longeveron
Speakers

Dan Stanton

Founder & Editor • Bioprocess Insider
Speakers

Dan Stanton

Founder and Editor • Bioprocess Insider
Speakers

Dan Strange

Head of Cell Therapy Technology • TTP
Speakers

Daniel C. Smith

Executive Director, Global Cell & Gene Therapy Portfolio • Charles River
Speakers

Daniel Chung

Chief Medical Officer • Sparing Vision
Speakers

Daniel Shelly

Vice President • Prescient Therapeutics
Speakers

Daniel Teasley

Head of Viral & Gene Therapy Products and Services • MilliporeSigma
Speakers

David Fontana

Chief Business and Strategy Officer • Umoja Biopharma
Speakers

David Hodl

Head of Business Development • Invetech
Speakers

David Pearce

President of Innovation, Research & World Clinic • Sanford Health
Speakers

David Peritt

Founder & Chief Scientific Officer • Lupagen
Speakers

David Sheehan

Founder and Chief Executive Officer • Nucleus Biologics
Speakers

Dawn Henke

Senior Technical Program Manager • Standards Coordinating Body
Speakers

Delara Motlagh

General Manager, Cell Therapy Technologies • Terumo Blood and Cell Technologies
Speakers

Dhvanit Shah

Founder, President and Chief Executive Officer • Garuda Therapeutics
Speakers

Diego Correa

Director, Medical Strategy Lead, Cell & Gene Therapy Center of Excellence • IQVIA
Speakers

Dominic Clarke

Chief Technology Officer • Discovery Life Sciences
Speakers

Donna Rill

Chief Technology Officer • Triumvira Immunologics
Speakers

Dr David DiGusto

Chief Technology Officer • Resilience
Speakers

Dr Raymond Stapleton

Executive Vice President, Pharmaceutical Services and Manufacturing • Genocea
Speakers

Dragan Djordjevic

Associate Director, Cell Therapy Robotics, Data Automation and Machine Learning • Takeda
Speakers

Edita Botonjic-Sehic

Director of Analytics, Digital Innovation • Pall Corporation
Speakers

Eduard Ayuso

Chief Technology Officer • DiNAQOR
Speakers

Emilie Gateau

Platform Development Manager • Exothera
Speakers

Emily Benz

Engineer II, Process Development • ViaCyte
Speakers

Emily English

Director of Quality • Cartesian Therapeutics
Speakers

Emma Bjorgum

Vice President, Client Services, DNA • Aldevron
Speakers

Emma Cheesman

Director of Development Consulting and Scientific Affairs • BioPharma Excellence
Speakers

Erwin Cammaart

Executive Director, Process Development • Iovance Biotherapeutics Inc
Speakers

Eugene Brandon

Head, Cell & Gene Therapy Translation • IQVIA
Speakers

Evan Zynda

Staff Scientist • Thermo Fisher Scientific Inc
Speakers

Fabian Gerlinghaus

Co-Founder and Chief Executive Officer • Cellares
Speakers

Fabio Fachin

Head of Cell Therapy Process Development, Automation and Digital Technologies • Takeda
Speakers

Farzin Farzaneh

Chief Scientific Officer & Co-Founder • ViroCell Biologics
Speakers

Félix Montero-Julian

 • bioMérieux
Speakers

Gabriella Perell

Cell and Gene Therapy Product Manager • Bio-Techne
Speakers

Garrie Richardson

General Manager, SciSafe • BioLife Solutions
Speakers

George Buchman

Vice President, Preclinical Service and Process Development • Catalent Cell and Gene Therapy
Speakers

George Smith

Vice President, Cell Therapy Operations • Turnstone Bio
Speakers

Géraldine Guérin-Peyrou

Director of Marketing and Scientific Support • Polyplus-Transfection
Speakers

Gerry Farrell

Chief Operating Officer • Fujifilm Diosynth Biotechnologies
Speakers

Hanna Lesch

Chief Technology Officer • Exothera
Speakers

Haro Hartounian

Senior Vice President and General Manager • BioCentriq
Speakers

Holly May

Chief Commercial Officer • AVROBIO
Speakers

Ian Goodwin

Associate Director, Global Program Design • Fujifilm Diosynth Biotechnologies
Speakers

Ian McNiece

Chief Scientific Officer • BioCardia
Speakers

Ivan Wall

Director, Advanced Therapies Manufacturing National Training Centre and Co-Founder & Director of FourPlus Immersive • FourPlus Immersive
Speakers

J Kelly Ganjei

President and Chief Executive Officer • AmplifyBio
Speakers

Jacob Becraft

Chief Executive Officer • Strand Therapeutics
Speakers

Jak Knowles

Chief Executive Officer • Affini T
Speakers

James Miskin

 • Oxford BioMedica (UK) Ltd
Speakers

James Wang

Chief Technology Officer • Juventas Cell Therapy
Speakers

Janet Lynch Lambert

Chief Executive Officer • Alliance for Regenerative Medicine
Speakers

Jason C. Foster

Chief Executive Officer • Ori Biotech
Speakers

Jeff Boyd

Partner and Life Sciences Tools & Services Sector Co-Leader • Heidrick & Struggles
Speakers

Jeff Liter

Chief Executive Officer • Luminary Therapeutics
Speakers

Jenessa Smith

Associate Director of Process Development • Arsenal Bio
Speakers

Jenna Dale

Director, Global Commercial Development • Cook MyoSite
Speakers

Jennifer Rabin

Next Gen Therapy Practice • Deloitte
Speakers

Jill Elliott

Vice President, Cell Therapy Commercialisation • Novo Nordisk
Speakers

Jim Furey

General Manager • PendoTECH
Speakers

Jo Anne Valentino

Chief Operating Officer • Minaris Regenerative Medicine
Speakers

Joachim Fruebis

Chief Development Officer • BlueRock Therapeutics
Speakers

Joe Garrity

Director, Commercial Development (CGT), Autologous Cell Therapy • Lonza Ltd
Speakers

John Kerwin

Technical Head of Gene Therapy Franchise  • Resilience
Speakers

John Manis

edical Director of Transfusion Medicine at Boston Children, Associated Faculty Kraft Family Blood Donor Center at Dana-Farber Cancer Institute and Brigham and Women’s Hospital,  Associate Professor of Pathology Harvard Medical School • Harvard Medical School
Speakers

John Maslowski

Chief Commercial Officer • Forge Biologics
Speakers

John Moscariello

Executive Director, Viral Vector & Gene Editing Process Development • Bristol Myer Squibb
Speakers

John Schick

Vice President, Global Market Access and Policy • Instil Bio
Speakers

Jon Ellis

Manager • Invetech
Speakers

Joseph (Yossi) Schwartz

Medical Director, Transfusion Medicine Quality Assurance • Mount Sinai Health System
Speakers

Joseph Micsko

Global Director, Process Manufacturing Technology • CAI
Speakers

Josh Ludwig

Global Director, Commercial Operations • ScaleReady
Speakers

Joy Aho

Senior Product Manager • Be The Match BioTherapies
Speakers

Judith Koliwer

Principal Consultant, Cell and Gene Therapy • Körber
Speakers

Julia Tarasenko

VP, Commercial Operations, EMEA and Americas • Marken
Speakers

Kei Kishimoto

Chief Scientific Officer • Selecta Bio
Speakers

Ken Rando

Business Development Manager • Comecer S.p.A
Speakers

Kent Christopherson

Senior Director, Medical Affairs • Orchard Therapeutics
Speakers

Kent Thorup

Regional Vice President of Business Development • QuickSTAT Global Life Science Logistics
Speakers

Kevin Ramdas

Director, Medical Affairs • Longeveron
Speakers

Kim Raineri

Chief Manufacturing and Technology Officer • AVROBIO
Speakers

Kimberly Negrin

Director, Cell Therapy Strategy and Business Operations • Charles River
Speakers

Krishendu Roy

Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT) • Georgia Tech
Speakers

Krishnan Viswanadhan

President and Chief Operating Officer • Be Biopharma
Speakers

Kurt Swogger

 • BioPact
Speakers

Kwok Pang

Chief Operating Officer and Co-Founder • Autolomous
Speakers

Laurent Humeau

Chief Science Officer • INOVIO
Speakers

Lavakumar Karyampudi

Technical Director, Cell Therapy Facility • Moffitt Cancer Center
Speakers

Leisha Kopp

Applications Scientist • Mirus Bio
Speakers

Lisa McClain-Moss

Vice President, Manufacturing • Longeveron
Speakers

Lisa Ward

 • Emily Whitehead Foundation
Speakers

Lizette Caballero

Regional CAR T Site Liaision • Janssen
Speakers

Louis Walcer

Director, The Kevin M. McGovern Family Center for Venture Development in the Life Sciences • Cornell University
Speakers

Lucas De Breed

Founder and Managing Director • August Care
Speakers

Ludwig Camusot

Chief Corporate Development Officer • Cell Matters
Speakers

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions
Speakers

Mamta Kalra

Director, Department of Chemistry, Manufacture and Control (CMC)  • Immatics
Speakers

Marco Fadda

ATMP Solutions Manager • Comecer S.p.A
Speakers

Mari Mitrani

Chief Science Officer • Organicell Regenerative Medicine
Speakers

Maria Croyle

Professor of Molecular Pharmaceutics and Drug Delivery/Glaxo Wellcome Professor • University of Texas at Austin
Speakers

Mark Sawicki

Chief Executive Officer • Cryoport Systems
Speakers

Mark Throsby

Chief Scientific Officer • Gadeta
Speakers

Mathias Svahn

Chief Executive Officer • NextCell Pharma
Speakers

Matthew Hewitt

Senior Director, Scientific Services, Cell and Gene Therapy • Charles River
Speakers

Matthew Lakelin

Vice President, Business Development and Scientific Affairs • TrakCel
Speakers

Matthew Li

Associate Director, Head of Cell Therapy Manufacturing Innovation • Vor Biopharma
Speakers

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings • American Red Cross
Speakers

Metin Kurtoglu

Chief GMP Manufacturing Officer • Cartesian Therapeutics
Speakers

Michael Blackton

Sr. Vice President, Cell Therapy Manufacturing, DeTIL Development • Nurix Therapeutics
Speakers

Michael Leek

Executive Chairman • TC BioPharm
Speakers

Michael Leek

Executive Chairman • TC BioPharm
Speakers

Michael Lehmicke

Senior Director, Science and Industry Affairs  • Alliance for Regenerative Medicine
Speakers

Michael Mercaldi

Senior Director, Downstream Process Development • Homology Medicines
Speakers

Michael Paglia

Chief Operating Officer • Elevate Bio
Speakers

Michael Titus

Vice President of Quality and Operations • AVOBIS BIO
Speakers

Miguel Forte

Chief Executive Officer • Bone Therapeutics
Speakers

Mike Orrico

Treasurer and Executive Committee • Standards Coordinating Body
Speakers

Nathalie Clement

Associate Program Director & Associate Professor • Powell Gene Therapy Center
Speakers

Nathan Moore

Associate Director, Manufacturing Technologies, Cell Therapies • Takeda
Speakers

Nathan Moore

Associate Director, Engineering & Automation, Cell Therapies • Takeda
Speakers

Nicholas Ostrout

Senior Director, Commercial Strategy and Implementation  • Lonza Ltd
Speakers

Nina Bauer

Senior Director, Head of Commercial, Gene Therapy • MilliporeSigma
Speakers

Ohad Karnieli

Founder & CEO • Adva Biotechnology
Speakers

Øystein Åmellem

Director, Cell Bio  • Thermo Fisher Scientific Inc
Speakers

Patrick Lucy

Chief Executive Officer • Lykan Bioscience
Speakers

Patrick Westmoreland

Principal Scientist, Viral Vector and Gene Editing Process Development  • Bristol Myer Squibb
Speakers

Paul Kosnik

Vice President, Clinical Development • Orgenesis
Speakers

Peter Danforth

Business Development Manager • Wacker Chemie
Speakers

Peter Marks

Director of the Center for Biologics Evaluation and Research  • FDA
Speakers

Peter Olagunju

Chief Technology Officer • TCR2 Therapeutics
Speakers

Peter Walters

Director, Advanced Therapies • CRB
Speakers

Peter Walters

Director, Advanced Therapies • CRB
Speakers

Phil Morton

Chief Technology Officer • Albumedix
Speakers

Pierre Axel Vinot

Associate Director, CMC Portfolio Management • Sparing Vision
Speakers

Pinar Cicalese

Director, CMC Commercial Strategy • Immatics
Speakers

Qian Hao

Chief Technology Officer • Porton Advanced
Speakers

Rachel Legmann

Director of Technology, Gene Therapy • Repligen
Speakers

Radmila Feldmann

Patient-Centric Supply Chain Solutions for Cell and Gene Therapies • Time:Matters
Speakers

Rhessa Diaz

Senior Manager of Cell Therapy Analysis • Bristol Myer Squibb
Speakers

Richard McFarland

Chief Regulatory Officer • ARMI
Speakers

Robert Lechich

Principal Consultant • Global OT/IT Quality Services
Speakers

Robert Newman

Chief Scientific Officer • Fujifilm Irvine Scientific
Speakers

Ryan Cawood

Chief Scientific Officer • WuXi Advanced Therapies
Speakers

Ryan Pruchnic

Managing Vice President • Cook MyoSite
Speakers

Sadaf Naz Khan

Regional CAR T Site Liaision • Janssen
Speakers

Sadik Kassim

Chief Technology Officer • Vor Biopharma
Speakers

Samik Basu

Chief Scientific Officer • Cabaletta Bio
Speakers

Sander Van Deventer

Chief Scientific Officer • Porton Advanced
Speakers

Sarah Thomas

Vice President of Quality • REGENXBIO
Speakers

Sean Werner

President • Sexton Biotechnologies
Speakers

Shannon Eaker

Cell and Gene Therapy Enterprise Technical Leader • Cytiva
Speakers

Sharon Brownlow

Chief Business Officer • Cell and Gene Therapy Catapult
Speakers

Shephard Mpofu

Senior Vice President & Chief Medical Officer • Novartis Gene Therapies
Speakers

Shepherd Mpofu

Chief Medical Officer • Novartis Gene Therapies
Speakers

Shyam Patal

Director of Business Development  • CIRM
Speakers

Stefanos Theoharis

Chief Business Officer • Bone Therapeutics
Speakers

Susan Nichols

President and Chief Executive Officer • Propel Biosciences
Speakers

Sven Kili

Chief Executive Officer • Antion
Speakers

Tamer Mohamed

President & Chief Executive Officer • Aspect Biosystems
Speakers

Tamer Mohamed

President & Chief Executive Officer • Aspect Biosystems
Speakers

Tania D. Pereira Chilima

Chief Technology Officer • Univercells Technologies
Speakers

Tara Crnkovich

Senior Director, Site Lead – Clinical Biologics & Cell Therapy Manufacturing • AstraZeneca
Speakers

Thomas Bollenbach

Chief Technology Officer • ARMI
Speakers

Tiffany Rau

Owner and Principal Consultant • Rau Consulting
Speakers

Tim Farries

Principal Consultant, Senior Director • BioPharma Excellence
Speakers

Timothy Schroeder

Chairman, Chief Executive Officer and Founder • CTI
Speakers

Todd Sulchek

Co-Founder • CellFe
Speakers

Tom Whitehead

Founder • Emily Whitehead Foundation
Speakers

Tony Ward

Chief Technology Officer • GPB Scientific, LLC
Speakers

Trent Carrier

Chief Operating Officer • L7 Informatics
Speakers

Vasu Rangadass

President & Chief Executive Officer • L7 Informatics
Speakers

Whitney Ijem

Senior Vice President, Strategy & Business Development • Krystal Biotech
Speakers

Will Chou

Chief Executive Officer • Aruvant
Speakers

Yina Santiago-Rodriguez

Process Development Manager • Fujifilm Cellular Dynamics